Nusano Stock
A developer of an advanced ion source and linear accelerator designed to overcome limitations in radioisotope manufacturing. The company offers uranium-free diagnostic and therapeutic radioisotopes, helping healthcare clients develop cost-effective radiopharmaceuticals for personalized cancer treatments.
Founded: 2016
For more Nusano stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Chris Lowe Chief Executive Officer |
| Howard Lewin, MD Co-Founder & Chief Product Development Officer |
| Glenn Rosenthal, PhD. Co-Founder & Chief Technology Officer |
| Pushkar Bedekar Chief Financial Officer |
